{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:18:31Z","timestamp":1791051511846,"version":"4.1.0"},"reference-count":72,"publisher":"International Society of Endovascular Specialists","issue":"SupplementII","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Endovascular Therapy"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1583\/08-2658.1","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T12:45:45Z","timestamp":1243860345000},"page":"II63-II81","source":"Crossref","is-referenced-by-count":32,"title":["Primary Nitinol Stenting for Femoropopliteal Disease"],"prefix":"10.1583","volume":"16","author":[{"given":"Mark W.","family":"Mewissen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"527","reference":[{"key":"i1545-1550-16-SupplementII-63-b1","unstructured":"J. A. Dormandy, and R. B. Rutherford .Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)., J Vasc Surg, 2000 .31 :(1 Pt 2).S1 \u2013S296 ."},{"key":"i1545-1550-16-SupplementII-63-b2","doi-asserted-by":"crossref","unstructured":"L. Norgren, W. R. Hiatt, and J. A. Dormandy .et al.Inter-Society consensus for the management of peripheral arterial disease (TASC II)., J Vasc Surg, 2007 .45 :(1 Suppl).S5 \u2013S67 .","DOI":"10.1016\/j.jvs.2006.12.037"},{"key":"i1545-1550-16-SupplementII-63-b3","doi-asserted-by":"crossref","unstructured":"S. P. Lyden, and H. B. Smouse .TASC II and the endovascular management of infrainguinal disease., J Endovasc Ther, 2009 .16 :(Suppl II).II5 \u2013II18 .","DOI":"10.1583\/08-2659.1"},{"key":"i1545-1550-16-SupplementII-63-b4","unstructured":"V. Dorrucci, Treatment of superficial femoral artery occlusive disease., J Cardiovasc Surg (Torino), 2004 .45 :193 \u2013201 ."},{"key":"i1545-1550-16-SupplementII-63-b5","doi-asserted-by":"crossref","unstructured":"J. Holm, B. Arfvidsson, and L. Jivegard .et al.Chronic lower limb ischaemia. A prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA)., Eur J Vasc Surg, 1991 .5 :517 \u2013522 .","DOI":"10.1016\/S0950-821X(05)80338-X"},{"key":"i1545-1550-16-SupplementII-63-b6","doi-asserted-by":"crossref","unstructured":"G. L. Wolf, S. E. Wilson, and A. P. Cross .et al.Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial. Principal investigators and their Associates of Veterans Administration Cooperative Study Number 199., J Vasc Interv Radiol, 1993 .4 :639 \u2013648 .","DOI":"10.1016\/S1051-0443(93)71939-9"},{"key":"i1545-1550-16-SupplementII-63-b7","doi-asserted-by":"crossref","unstructured":"E. S. van der Zaag, D. A. Legemate, and M. H. Prins .et al.Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial., Eur J Vasc Endovasc Surg, 2004 .28 :132 \u2013137 .","DOI":"10.1016\/j.ejvs.2004.04.003"},{"key":"i1545-1550-16-SupplementII-63-b8","doi-asserted-by":"crossref","unstructured":"S. M. Surowiec, M. G. Davies, and S. W. Eberly .et al.Percutaneous angioplasty and stenting of the superficial femoral artery., J Vasc Surg, 2005 .41 :269 \u2013278 .","DOI":"10.1016\/j.jvs.2004.11.031"},{"key":"i1545-1550-16-SupplementII-63-b9","doi-asserted-by":"crossref","unstructured":"D. J. Adam, and J. D. Beard .et al.Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial., Lancet, 2005 .366 :1925 \u20131934 .","DOI":"10.1016\/S0140-6736(05)67704-5"},{"key":"i1545-1550-16-SupplementII-63-b10","doi-asserted-by":"crossref","unstructured":"J. R. Laird, Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries., J Endovasc Ther, 2006 .13 Suppl 2 :II30 \u201340 .","DOI":"10.1177\/15266028060130S207"},{"key":"i1545-1550-16-SupplementII-63-b11","unstructured":"P. Capek, G. K. McLean, and H. D. Berkowitz .Femoropopliteal angioplasty. Factors influencing long-term success., Circulation, 1991 .83 :(2 Suppl).I70 \u201380 ."},{"key":"i1545-1550-16-SupplementII-63-b12","doi-asserted-by":"crossref","unstructured":"K. W. Johnston, Femoral and popliteal arteries: reanalysis of results of balloon angioplasty., Radiology, 1992 .183 :767 \u2013771 .","DOI":"10.1148\/radiology.183.3.1294068"},{"key":"i1545-1550-16-SupplementII-63-b13","doi-asserted-by":"crossref","unstructured":"I. I. Galaria, S. M. Surowiec, and J. M. Rhodes .et al.Percutaneous and open renal revascularizations have equivalent long-term functional outcomes., Ann Vasc Surg, 2005 .19 :218 \u2013228 .","DOI":"10.1007\/s10016-004-0165-8"},{"key":"i1545-1550-16-SupplementII-63-b14","doi-asserted-by":"crossref","unstructured":"M. G. Davies, W. E. Saad, and E. K. Peden .et al.Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss., J Vasc Surg, 2008 .48 :619 \u2013626 .","DOI":"10.1016\/j.jvs.2008.04.013"},{"key":"i1545-1550-16-SupplementII-63-b15","doi-asserted-by":"crossref","unstructured":"M. G. Davies, W. E. Saad, and E. K. Peden .et al.Percutaneous superficial femoral artery interventions for claudication-does runoff matter? Ann Vasc Surg, 2008 .22 :790 \u2013798 .","DOI":"10.1016\/j.avsg.2008.04.007"},{"key":"i1545-1550-16-SupplementII-63-b16","doi-asserted-by":"crossref","unstructured":"M. G. Hunink, J. B. Wong, and M. C. Donaldson .et al.Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis., JAMA, 1995 .274 :165 \u2013171 .","DOI":"10.1001\/jama.274.2.165"},{"key":"i1545-1550-16-SupplementII-63-b17","doi-asserted-by":"crossref","unstructured":"K. R. Goshima, J. L. Mills, and J. D. Hughes .A new look at outcomes after infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage., J Vasc Surg, 2004 .39 :330 \u2013335 .","DOI":"10.1016\/j.jvs.2003.10.020"},{"key":"i1545-1550-16-SupplementII-63-b18","doi-asserted-by":"crossref","unstructured":"B. H. Gray, T. M. Sullivan, and M. B. Childs .et al.High incidence of restenosis\/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty., J Vasc Surg, 1997 .25 :74 \u201383 .","DOI":"10.1016\/S0741-5214(97)70323-9"},{"key":"i1545-1550-16-SupplementII-63-b19","doi-asserted-by":"crossref","unstructured":"J. P. Becquemin, J. P. Favre, and J. Marzelle .et al.Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study., J Vasc Surg, 2003 .37 :487 \u2013494 .","DOI":"10.1067\/mva.2003.155"},{"key":"i1545-1550-16-SupplementII-63-b20","doi-asserted-by":"crossref","unstructured":"M. Cejna, S. Thurnher, and H. Illiasch .et al.PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study., J Vasc Interv Radiol, 2001 .12 :23 \u201331 .","DOI":"10.1016\/S1051-0443(07)61397-9"},{"key":"i1545-1550-16-SupplementII-63-b21","doi-asserted-by":"crossref","unstructured":"D. Vroegindeweij, L. D. Vos, and A. V. Tielbeek .et al.Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study., Cardiovasc Intervent Radiol, 1997 .20 :420 \u2013425 .","DOI":"10.1007\/s002709900186"},{"key":"i1545-1550-16-SupplementII-63-b22","doi-asserted-by":"crossref","unstructured":"M. J. Costanza, L. A. Queral, and M. P. Lilly .et al.Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus type B femoropopliteal arterial occlusive lesions., J Vasc Surg, 2004 .39 :343 \u2013350 .","DOI":"10.1016\/j.jvs.2003.07.007"},{"key":"i1545-1550-16-SupplementII-63-b23","doi-asserted-by":"crossref","unstructured":"J. Grimm, S. M\u00fcller-H\u00fclsbeck, and T. Jahnke .et al.Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions., J Vasc Interv Radiol, 2001 .12 :935 \u2013942 .","DOI":"10.1016\/S1051-0443(07)61572-3"},{"key":"i1545-1550-16-SupplementII-63-b24","unstructured":"Z. Zdanowski, U. Albrechtsson, and A. Lundin .et al.Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study., Int Angiol, 1999 .18 :251 \u2013255 ."},{"key":"i1545-1550-16-SupplementII-63-b25","unstructured":"B. H. Gray, and J. W. Olin .Limitations of percutaneous transluminal angioplasty with stenting for femoropopliteal arterial occlusive disease., Semin Vasc Surg, 1997 .10 :8 \u201316 ."},{"key":"i1545-1550-16-SupplementII-63-b26","doi-asserted-by":"crossref","unstructured":"E. Tetteroo, Y. van der Graaf, and J. L. Bosch .et al.Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group., Lancet, 1998 .351 :1153 \u20131159 .","DOI":"10.1016\/S0140-6736(97)09508-1"},{"key":"i1545-1550-16-SupplementII-63-b27","doi-asserted-by":"crossref","unstructured":"M. Schillinger, S. Sabeti, and C. Loewe .et al.Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery., N Engl J Med, 2006 .354 :1879 \u20131888 .","DOI":"10.1056\/NEJMoa051303"},{"key":"i1545-1550-16-SupplementII-63-b28","doi-asserted-by":"crossref","unstructured":"M. W. Mewissen, Stenting in the femoropopliteal arterial segment., Tech Vasc Interv Radiol, 2005 .8 :146 \u2013149 .","DOI":"10.1053\/j.tvir.2006.05.003"},{"key":"i1545-1550-16-SupplementII-63-b30","doi-asserted-by":"crossref","unstructured":"S. H. Duda, J. Wiskirchen, and G. Tepe .et al.Physical properties of endovascular stents: an experimental comparison., J Vasc Interv Radiol, 2000 .11 :645 \u2013654 .","DOI":"10.1016\/S1051-0443(07)61620-0"},{"key":"i1545-1550-16-SupplementII-63-b31","unstructured":"B. Wiesinger, S. Heller, and J. Schmehl .et al.Percutaneous vascular interventions in the superficial femoral artery. A review., Minerva Cardioangiol, 2006 .54 :83 \u201393 ."},{"key":"i1545-1550-16-SupplementII-63-b32","doi-asserted-by":"crossref","unstructured":"G. M. Ansel, C. F. Botti, and B. S. George .et al.Clinical results for the training-phase roll-in patients in the Intracoil femoropopliteal stent trial., Catheter Cardiovasc Interv, 2002 .56 :443 \u2013449 .","DOI":"10.1002\/ccd.10252"},{"key":"i1545-1550-16-SupplementII-63-b33","doi-asserted-by":"crossref","unstructured":"D. Greenberg, K. Rosenfield, and L. A. Garcia .et al.In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial)., J Vasc Interv Radiol, 2004 .15 :1065 \u20131069 .","DOI":"10.1097\/01.RVI.0000136293.18041.88"},{"key":"i1545-1550-16-SupplementII-63-b34","doi-asserted-by":"crossref","unstructured":"T. Jahnke, G. Voshage, and S. M\u00fcller-H\u00fclsbeck .et al.Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease., J Vasc Interv Radiol, 2002 .13 :257 \u2013266 .","DOI":"10.1016\/S1051-0443(07)61718-7"},{"key":"i1545-1550-16-SupplementII-63-b35","doi-asserted-by":"crossref","unstructured":"M. Ferreira, L. Lanziotti, and M. Monteiro .et al.Superficial femoral artery recanalization with self-expanding nitinol stents: long-term follow-up results., Eur J Vasc Endovasc Surg, 2007 .34 :702 \u2013708 .","DOI":"10.1016\/j.ejvs.2007.07.025"},{"key":"i1545-1550-16-SupplementII-63-b36","doi-asserted-by":"crossref","unstructured":"M. W. Mewissen, Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results., Tech Vasc Interv Radiol, 2004 .7 :2 \u20135 .","DOI":"10.1053\/j.tvir.2004.01.007"},{"key":"i1545-1550-16-SupplementII-63-b37","doi-asserted-by":"crossref","unstructured":"G. M. Ansel, M. J. Silver, and C. F. Botti .et al.Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: a randomized trial., Catheter Cardiovasc Interv, 2006 .67 :288 \u2013297 .","DOI":"10.1002\/ccd.20593"},{"key":"i1545-1550-16-SupplementII-63-b38","doi-asserted-by":"crossref","unstructured":"O. Iida, S. Nanto, and M. Uematsu .et al.Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions., J Vasc Surg, 2008 .48 :144 \u2013149 .","DOI":"10.1016\/j.jvs.2008.02.062"},{"key":"i1545-1550-16-SupplementII-63-b39","doi-asserted-by":"crossref","unstructured":"M. Jaff, M. Dake, and J. Pompa .et al.Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices., Catheter Cardiovasc Interv, 2007 .70 :460 \u2013462 .","DOI":"10.1002\/ccd.21240"},{"key":"i1545-1550-16-SupplementII-63-b40","doi-asserted-by":"crossref","unstructured":"G. M. Ansel, and A. B. Lumsden .Evolving modalities for femoropopliteal interventions., J Endovasc Ther, 2009 .16 :(Suppl II).II00 \u201300 .","DOI":"10.1583\/08-2654.1"},{"key":"i1545-1550-16-SupplementII-63-b41","doi-asserted-by":"crossref","unstructured":"T. Das, T. McNamara, and B. Gray .et al.Primary cryoplasty therapy provides durable support for limb salvage in CLI patients with infrapopliteal lesions: 12-month follow-up results from the BTK Chill trial., J Endovasc Ther, 2009 .16 :(Suppl II).II00 \u201300 .","DOI":"10.1583\/08-2652.1"},{"key":"i1545-1550-16-SupplementII-63-b42","doi-asserted-by":"crossref","unstructured":"J. R. Laird, and D. L. Dawson .The role for cryoplasty in the treatment of infrainguinal artery disease: case studies., J Endovasc Ther, 2009 .16 :(Suppl II).II116 \u2013II128 .","DOI":"10.1583\/08-2653.1"},{"key":"i1545-1550-16-SupplementII-63-b43","doi-asserted-by":"crossref","unstructured":"T. S. Das, Excimer laser-assisted angioplasty for infrainguinal artery disease., J Endovasc Ther, 2009 .16 :(Suppl II).II98 \u2013II104 .","DOI":"10.1583\/08-2655.1"},{"key":"i1545-1550-16-SupplementII-63-b44","doi-asserted-by":"crossref","unstructured":"L. A. Garcia, and S. P. Lyden .Atherectomy for infrainguinal peripheral artery disease., J Endovasc Ther, 2009 .16 :(Suppl II).II105 \u2013II115 .","DOI":"10.1583\/08-2656.1"},{"key":"i1545-1550-16-SupplementII-63-b45","doi-asserted-by":"crossref","unstructured":"S. H. Duda, M. Bosiers, and J. Lammer .et al.Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial., J Endovasc Ther, 2006 .13 :701 \u2013710 .","DOI":"10.1583\/05-1704.1"},{"key":"i1545-1550-16-SupplementII-63-b46","doi-asserted-by":"crossref","unstructured":"N. Hynes, Y. Akhtar, and B. Manning .et al.Subintimal angioplasty as a primary modality in the management of critical limb ischemia: comparison to bypass grafting for aortoiliac and femoropopliteal occlusive disease., J Endovasc Ther, 2004 .11 :460 \u2013471 .","DOI":"10.1583\/04-1242.1"},{"key":"i1545-1550-16-SupplementII-63-b47","doi-asserted-by":"crossref","unstructured":"M. Akesson, L. Riva, and K. Ivancev .et al.Subintimal angioplasty of infrainguinal arterial occlusions for critical limb ischemia: long-term patency and clinical efficacy., J Endovasc Ther, 2007 .14 :444 \u2013451 .","DOI":"10.1177\/152660280701400403"},{"key":"i1545-1550-16-SupplementII-63-b48","doi-asserted-by":"crossref","unstructured":"O. Schlager, P. Dick, and S. Sabeti .et al.Long-segment SFA stenting\u2013the dark sides: in-stent restenosis, clinical deterioration, and stent fractures., J Endovasc Ther, 2005 .12 :676 \u2013684 .","DOI":"10.1583\/05-1672.1"},{"key":"i1545-1550-16-SupplementII-63-b49","doi-asserted-by":"crossref","unstructured":"R. R. Saxon, J. M. Coffman, and J. M. Gooding .et al.Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions., J Vasc Interv Radiol, 2007 .18 :1341 \u20131349 .","DOI":"10.1016\/j.jvir.2007.07.011"},{"key":"i1545-1550-16-SupplementII-63-b50","doi-asserted-by":"crossref","unstructured":"R. R. Saxon, M. D. Dake, and R. L. Volgelzang .et al.Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease., J Vasc Interv Radiol, 2008 .19 :823 \u2013832 .","DOI":"10.1016\/j.jvir.2008.02.008"},{"key":"i1545-1550-16-SupplementII-63-b51","doi-asserted-by":"crossref","unstructured":"A. B. Lumsden, M. G. Davies, and E. K. Peden .Medical and endovascular management of critical limb ischemia., J Endovasc Ther, 2009 .16 :(Suppl II).II31 \u2013II62 .","DOI":"10.1583\/08-2657.1"},{"key":"i1545-1550-16-SupplementII-63-b52","doi-asserted-by":"crossref","unstructured":"S. H. Duda, B. Pusich, and G. Richter .et al.Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results., Circulation, 2002 .106 :1505 \u20131509 .","DOI":"10.1161\/01.CIR.0000029746.10018.36"},{"key":"i1545-1550-16-SupplementII-63-b53","doi-asserted-by":"crossref","unstructured":"S. H. Duda, M. Bosiers, and J. Lammer .et al.Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial., J Vasc Interv Radiol, 2005 .16 :331 \u2013338 .","DOI":"10.1097\/01.RVI.0000151260.74519.CA"},{"key":"i1545-1550-16-SupplementII-63-b55","doi-asserted-by":"crossref","unstructured":"T. R. Vogel, L. E. Shindelman, G. B. Nackman, and A. M. Graham .Efficacious use of nitinol stents in the femoral and popliteal arteries., J Vasc Surg, 2003 .38 :1178 \u20131184 .","DOI":"10.1016\/j.jvs.2003.09.011"},{"key":"i1545-1550-16-SupplementII-63-b56","doi-asserted-by":"crossref","unstructured":"S. Sabeti, W. Mlekusch, and J. Amighi .et al.Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries., J Endovasc Ther, 2005 .12 :6 \u201312 .","DOI":"10.1583\/04-1359.1"},{"key":"i1545-1550-16-SupplementII-63-b57","doi-asserted-by":"crossref","unstructured":"D. Scheinert, S. Scheinert, and J. Sax .et al.Prevalence and clinical impact of stent fractures after femoropopliteal stenting., J Am Coll Cardiol, 2005 .45 :312 \u2013315 .","DOI":"10.1016\/j.jacc.2004.11.026"},{"key":"i1545-1550-16-SupplementII-63-b58","unstructured":"G. M. Ansel, Clinical significance of stent fractures (interview)., Endovascular Today, 2006 .May :37 \u201340 ."},{"key":"i1545-1550-16-SupplementII-63-b59","doi-asserted-by":"crossref","unstructured":"M. Schillinger, S. Sabeti, and P. Dick .et al.Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting., Circulation, 2007 .115 :2745 \u20132749 .","DOI":"10.1161\/CIRCULATIONAHA.107.688341"},{"key":"i1545-1550-16-SupplementII-63-b60","unstructured":"J. Laird, Lessons learned in RESILIENT (interview)., Endovascular Today, 2008 .October :59 \u201362 ."},{"key":"i1545-1550-16-SupplementII-63-b61","doi-asserted-by":"crossref","unstructured":"H. Krankenberg, M. Schluter, and H. J. Steinkamp .et al.Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST)., Circulation, 2007 .116 :285 \u2013292 .","DOI":"10.1161\/CIRCULATIONAHA.107.689141"},{"key":"i1545-1550-16-SupplementII-63-b62","doi-asserted-by":"crossref","unstructured":"T. Zeller, C. Tiefenbacher, and H. J. Steinkamp .et al.Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT)., J Endovasc Ther, 2008 .15 :390 \u2013398 .","DOI":"10.1583\/08-2461.1"},{"key":"i1545-1550-16-SupplementII-63-b64","doi-asserted-by":"crossref","unstructured":"M. Bosiers, C. Cagiannos, and K. Deloose .et al.Drug-eluting stents in the management of peripheral arterial disease., Vasc Health Risk Manag, 2008 .4 :553 \u2013559 .","DOI":"10.2147\/VHRM.S1712"},{"key":"i1545-1550-16-SupplementII-63-b65","unstructured":"M. Dake, The Zilver PTX global registry and RCT (interview)., Endovascular Today, 2008 .October.63 \u201364 ."},{"key":"i1545-1550-16-SupplementII-63-b66","unstructured":"K. Rocha-Singh, The DURABILITY II Trial (interview)., Endovascular Today, 2008 .October :66 \u201368 ."},{"key":"i1545-1550-16-SupplementII-63-b67","doi-asserted-by":"crossref","unstructured":"K. J. Rocha-Singh, M. R. Jaff, and T. R. Crabtree .et al.Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease., Catheter Cardiovasc Interv, 2007 .69 :910 \u2013919 .","DOI":"10.1002\/ccd.21104"},{"key":"i1545-1550-16-SupplementII-63-b68","doi-asserted-by":"crossref","unstructured":"L. Machan, Drug eluting stents in the infrainguinal circulation., Tech Vasc Interv Radiol, 2004 .7 :28 \u201332 .","DOI":"10.1053\/j.tvir.2004.01.004"},{"key":"i1545-1550-16-SupplementII-63-b69","doi-asserted-by":"crossref","unstructured":"K. Rosenfield, R. Schainfeld, and A. Pieczek .et al.Restenosis of endovascular stents from stent compression., J Am Coll Cardiol, 1997 .29 :328 \u2013338 .","DOI":"10.1016\/S0735-1097(96)00498-6"},{"key":"i1545-1550-16-SupplementII-63-b70","doi-asserted-by":"crossref","unstructured":"E. Babalik, M. Gulbaran, and T. Gurmen .et al.Fracture of popliteal artery stents., Circ J, 2003 .67 :643 \u2013645 .","DOI":"10.1253\/circj.67.643"},{"key":"i1545-1550-16-SupplementII-63-b71","unstructured":"D. Allie, C. Hebert, and C. Walker .Nitinol stent fractures in the SFA., Endovascular Today, 2004 .July\/August :22 \u201334 ."},{"key":"i1545-1550-16-SupplementII-63-b72","doi-asserted-by":"crossref","unstructured":"O. Iida, S. Nanto, and M. Uematsu .et al.Effect of exercise on frequency of stent fracture in the superficial femoral artery., Am J Cardiol, 2006 .98 :272 \u2013274 .","DOI":"10.1016\/j.amjcard.2006.01.091"},{"key":"i1545-1550-16-SupplementII-63-b73","unstructured":"D. Brunk, Drug-eluting stent proves durable at 6- and 12-month follow-up., Am Coll Surg: Surg News, 2008 .4 :12 ."},{"key":"i1545-1550-16-SupplementII-63-b74","doi-asserted-by":"crossref","unstructured":"R. B. Rutherford, J. D. Baker, and C. Ernst .et al.Recommended standards for reports dealing with lower extremity ischemia: revised version., J Vasc Surg, 1997 .26 :517 \u2013538 .","DOI":"10.1016\/S0741-5214(97)70045-4"},{"key":"i1545-1550-16-SupplementII-63-b75","doi-asserted-by":"crossref","unstructured":"N. Diehm, I. Baumgartner, and M. Jaff .et al.A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries., Eur Heart J, 2007 .28 :798 \u2013805 .","DOI":"10.1093\/eurheartj\/ehl545"}],"container-title":["Journal of Endovascular Therapy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:29:08Z","timestamp":1777498148000},"score":1,"resource":{"primary":{"URL":"http:\/\/jet.sagepub.com\/lookup\/doi\/10.1583\/08-2658.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":72,"journal-issue":{"issue":"SupplementII","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1583\/08-2658.1"],"URL":"https:\/\/doi.org\/10.1583\/08-2658.1","relation":{},"ISSN":["1526-6028","1545-1550"],"issn-type":[{"value":"1526-6028","type":"print"},{"value":"1545-1550","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}